147 related articles for article (PubMed ID: 38234891)
1. Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients.
Tuncer SB; Celik B; Kılıc Erciyas S; Sukruoglu Erdogan O; Pasin O; Avsar M; Kurt Gultaslar B; Adamnejad Ghafour A; Uyaroglu G; Akdeniz Odemis D; Yazıcı H
Heliyon; 2024 Jan; 10(1):e23876. PubMed ID: 38234891
[TBL] [Abstract][Full Text] [Related]
2. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
[TBL] [Abstract][Full Text] [Related]
3. Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis.
Guo H; Zeng X; Li H; Guo Y; Wang T; Guo H; Zhu G; Wang L; Zhou H; Liu K; Chen X; Wang H; Zhao X; Su H; Li Y
An Acad Bras Cienc; 2020; 92(1):e20181203. PubMed ID: 32321013
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer.
Mazza T; Gioffreda D; Fontana A; Biagini T; Carella M; Palumbo O; Maiello E; Bazzocchi F; Andriulli A; Tavano F
Front Oncol; 2020; 10():44. PubMed ID: 32117716
[TBL] [Abstract][Full Text] [Related]
5. microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C.
Nan Y; Niu X; Wang R; Zhao S; Fu N; Du J; Wang Y; Wang B; Zhang Y
Exp Ther Med; 2019 Mar; 17(3):1817-1824. PubMed ID: 30783454
[TBL] [Abstract][Full Text] [Related]
6. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
[TBL] [Abstract][Full Text] [Related]
8. Five serum microRNAs for detection and predicting of ovarian cancer.
Wang W; Wu LR; Li C; Zhou X; Liu P; Jia X; Chen Y; Zhu W
Eur J Obstet Gynecol Reprod Biol X; 2019 Jul; 3():100017. PubMed ID: 31404211
[TBL] [Abstract][Full Text] [Related]
9. miRNA-1273g-3p Involvement in Development of Diabetic Retinopathy by Modulating the Autophagy-Lysosome Pathway.
Ye Z; Li ZH; He SZ
Med Sci Monit; 2017 Dec; 23():5744-5751. PubMed ID: 29197896
[TBL] [Abstract][Full Text] [Related]
10. Identification and potential value of candidate microRNAs in granulosa cells of polycystic ovary syndrome.
Wang Y; Xu S; Wang Y; Qi G; Hou Y; Sun C; Wu X
Technol Health Care; 2019; 27(6):579-587. PubMed ID: 30932905
[TBL] [Abstract][Full Text] [Related]
11. Role of a novel circulatory RNA-based biomarker panel expression in ovarian cancer.
El-Shal AS; Matboli M; Abdelaziz AM; Morsy AA; Abdelbary EH
IUBMB Life; 2019 Dec; 71(12):2031-2047. PubMed ID: 31520466
[TBL] [Abstract][Full Text] [Related]
12. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
Xu H; Mao HL; Zhao XR; Li Y; Liu PS
J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
[TBL] [Abstract][Full Text] [Related]
13. miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer.
Gao G; Guo X; Gu W; Lu Y; Chen Z
Aging (Albany NY); 2022 Apr; 14(8):3387-3399. PubMed ID: 35489022
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
15. miR-1273g-3p participates in acute glucose fluctuation-induced autophagy, dysfunction, and proliferation attenuation in human umbilical vein endothelial cells.
Guo J; Sang Y; Yin T; Wang B; Yang W; Li X; Li H; Kang Y
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E734-43. PubMed ID: 26908504
[TBL] [Abstract][Full Text] [Related]
16. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
[TBL] [Abstract][Full Text] [Related]
17. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
Zheng J; Zhou Y; Li XJ; Hu JM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
[TBL] [Abstract][Full Text] [Related]
18. miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.
Wu F; Liu F; Dong L; Yang H; He X; Li L; Zhao L; Jin S; Li G
Cancer Lett; 2018 Oct; 435():1-9. PubMed ID: 30056111
[TBL] [Abstract][Full Text] [Related]
19. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
Feng S; Luo S; Ji C; Shi J
World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Expression Level of miR-3135b-5p in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity.
Zare N; Dana N; Mosayebi A; Vaseghi G; Javanmard SH
Indian J Clin Biochem; 2023 Oct; 38(4):536-540. PubMed ID: 37746544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
